Journal Article Review Research Support, Non-U.S. Gov't Epublish 40 citations
PubMed: 37726282 DOI: 10.1038/s41392-023-01580-8
The role of cell death in SARS-CoV-2 infection.
Signal Transduct Target Ther 8(1):357
Authors: Cui Yuan, Zhenling Ma, Jiufeng Xie, Wenqing Li, Lijuan Su, Guozhi Zhang, Jun Xu, Yaru Wu, Min Zhang, Wei Liu
Affiliations
- College of Life Sciences, Henan Agricultural University, Zhengzhou, China.
- College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China.
- College of Life Sciences, Henan Agricultural University, Zhengzhou, China.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), showing high infectiousness, resulted in an ongoing pandemic termed coronavirus disease 2019 (COVID-19). COVID-19 cases often experience acute respiratory distress syndrome, which has caused millions of deaths. Apart from triggering inflammatory and immune responses, many viral infections can cause programmed cell death in infected cells. Cell death mechanisms have a vital role in maintaining a suitable environment to achieve normal cell functionality. Nonetheless, these processes are dysregulated, potentially contributing to disease pathogenesis. Over the past decades, multiple cell death pathways are becoming better understood. Growing evidence suggests that the induction of cell death by the coronavirus may significantly contributes to viral infection and pathogenicity. However, the interaction of SARS-CoV-2 with cell death, together with its associated mechanisms, is yet to be elucidated. In this review, we summarize the existing evidence concerning the molecular modulation of cell death in SARS-CoV-2 infection as well as viral-host interactions, which may shed new light on antiviral therapy against SARS-CoV-2.
MeSH
Infections, Signal Transduction, Virus Diseases, Cells, Cell Death, Respiratory Distress Syndrome, Coronavirus, Sars Virus, Covid-19, Sars-Cov-2
Cited by
- Evaluation of the Cytotoxic and Antiviral Effects of Small Molecules Selected by In Silico Studies as Inhibitors of SARS-CoV-2 Cell Entry. Molecules, 2023
- The role of reactive oxygen species in severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection-induced cell death. Cell Mol Biol Lett, 2024
- Insights into SARS-CoV-2: Small-Molecule Hybrids for COVID-19 Treatment. Molecules, 2024
- Leveraging viral genome sequences and machine learning models for identification of potentially selective antiviral agents. Commun Chem, 2025
- 4D-DIA Proteomics Uncovers New Insights into Host Salivary Response Following SARS-CoV-2 Omicron Infection. J Proteome Res, 2025
- Innate immunity, therapeutic targets and monoclonal antibodies in SARS-CoV-2 infection. PeerJ, 2025
- Cyclooxygenase-2/Prostaglandin E2 Pathway Facilitates Infectious Bronchitis Virus-Induced Necroptosis in Chicken Macrophages, a Caspase-Independent Cell Death. Viruses, 2025
- Bid Protein: A Participant in the Apoptotic Network with Roles in Viral Infections. Int J Mol Sci, 2025
- ALBACOVIDIOL Study: Effect of Calcifediol Treatment on Mortality in Patients Hospitalized for COVID-19: A Retrospective Analysis. Nutrients, 2025
- Ferroptosis: a key driver and therapeutic target in the pathogenesis of acute respiratory distress syndrome. Front Immunol, 2025
- Similar Spatial Expression of Immune-Related Proteins in SARS-CoV-2 Placentitis and Chronic Histiocytic Intervillositis. Eur J Immunol, 2025
- Peripheral immune progression to long COVID is associated with mitochondrial gene transcription: A meta-analysis. Mitochondrion, 2025
- Chromatin Regulator SMARCA4 Is Essential for MHV-Induced Inflammatory Cell Death, PANoptosis. Viruses, 2024
- Prognostic Value of Caspase-3 and Cardiac Troponin I in Assessing Cardiovascular Risk in Pediatric COVID-19 and Multisystem Inflammatory Syndrome. J Multidiscip Healthc, 2025
- Building an Adverse Outcome Pathway network for COVID-19. Front Syst Biol, 2025
- Genetic Conservation and Diversity of SARS-CoV-2 Envelope Gene Across Variants of Concern. J Med Virol, 2025
- Stress granules and cell death: crosstalk and potential therapeutic strategies in infectious diseases. Cell Death Dis, 2025
- Lesser-known non-apoptotic programmed cell death in viral infections. Virus Res, 2025
- Blood-derived product therapies for SARS-CoV-2 infection and long COVID. MedComm (2020), 2023
- Transcriptomic profiling of severe and critical COVID-19 patients reveals alterations in expression, splicing and polyadenylation. Sci Rep, 2025